Background: To date, coronavirus disease 2019 (COVID-19) becomes increasingly fierce
due to the emergence of variants. Rapid herd immunity through vaccination is needed to …

The development of effective vaccines to combat infectious diseases is a complex multi-year
and multi-stakeholder process. To accelerate the development of vaccines for coronavirus …

Abstract Coronavirus disease 2019 (COVID‐19) has brought about a great threat to global
public health. Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS …

Background Vaccination, one of the most important and effective ways of preventing
infectious diseases, has recently been used to control the COVID-19 pandemic. The present …

Since the start of the COVID-19 pandemic, numerous variants of SARS-CoV-2 have been
reported worldwide. The advent of variants of concern (VOCs) raises severe concerns amid …

Background Emerging and future SARS-CoV-2 variants may jeopardize the effectiveness of
vaccination campaigns. Therefore, it is important to know how the different vaccines perform …

Billions of doses of coronavirus disease 2019 (COVID-19) vaccines have been administered
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …

COVID-19 vaccine effectiveness by product (two doses Comirnaty, Spikevax or Vaxzevria
and one of Janssen), against infection ranged from 50%(95% CI: 42 to 57) for Janssen to …

Several studies report high effectiveness of COVID-19 vaccines against SARS-CoV-2
infection and severe disease, however an important knowledge gap is the vaccine …

There are serious concerns with rising antimicrobial resistance (AMR) across countries
increasing morbidity, mortality and costs. These concerns have resulted in a plethora of …